Keywords: واکسن سه واکنش آنفلوانزا; Influenza; Cost-effectiveness; Vaccination; Trivalent; Quadrivalent; Dynamic transmission model; GDP; gross domestic product; ICER; incremental cost-effectiveness ratio; HIV; human immunodeficiency virus; IBS; individual based simulation; I$; internationa
مقالات ISI واکسن سه واکنش آنفلوانزا (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: واکسن سه واکنش آنفلوانزا; Anaphylaxis; vaccine safety; immunization; DT; Diphtheria and tetanus toxoids; DTaP and Tdap; Diphtheria, tetanus, and acellular pertussis vaccines; ED; Emergency department; HAV; Hepatitis AÂ vaccine; HPV; Human papillomavirus vaccine; HZV; Herpes zoster
Keywords: واکسن سه واکنش آنفلوانزا; HAI; hemagglutination inhibition assay; HbA1c; glycosylated hemoglobin; T2D; type 2 diabetes; TIV; trivalent influenza vaccine; Obesity; Diabetes; Influenza vaccine; Antibody and immune response;
Keywords: واکسن سه واکنش آنفلوانزا; TIV; trivalent influenza vaccine; HR; hazards ratio; CI; confidence interval; VE; vaccine effectiveness; VHA; Valencia Health Agency; HSA; hospital service area; VAHNSI; Valencia Hospital Network for the Study of Influenza and Respiratory Virus Diseases;
Keywords: واکسن سه واکنش آنفلوانزا; APC; antigen presenting cell; BPL; beta-propiolactone; CI; confidence interval; DS; double stranded; GMC; geometric mean concentration; HA; haemagglutinin; HEK; human embryonic kidney; HI; haemagglutination inhibition assay; MPH; monovalent pooled harvest
Birth outcomes following immunization of pregnant women with pandemic H1N1 influenza vaccine 2009-2010
Keywords: واکسن سه واکنش آنفلوانزا; ACIP; Advisory Committee on Immunization Practices; CDC; Centers for Disease Control and Prevention; CI; Confidence Interval; ICD-9; The International Classification of Diseases, 9th Revision; KPNC; Kaiser Permanente of Northern California; LBW; Low birth
Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outc
Keywords: واکسن سه واکنش آنفلوانزا; Influenza vaccine; Effectiveness; Hospitalization; Serious outcomes; VE; vaccine effectiveness; ICU; intensive care unit; MV; mechanical ventilation; TIV; trivalent influenza vaccine; y; years of age; CIRN; Canadian Immunization Research Network; SOS; Ser
Manipulation of neuraminidase packaging signals and hemagglutinin residues improves the growth of A/Anhui/1/2013 (H7N9) influenza vaccine virus yield in eggs
Keywords: واکسن سه واکنش آنفلوانزا; Influenza A H7N9 virus; Vaccine virus; Packaging signals; Chimeric NA; Egg adaptation; H7 HA egg-adaptive mutations; HA; hemagglutinin; NA; neuraminidase; WT; wild-type; CVV; candidate vaccine virus; ORF; open reading frame; NCR; non-coding region; nt; nu
The in vitro MIMIC® platform reflects age-associated changes in immunological responses after influenza vaccination
Keywords: واکسن سه واکنش آنفلوانزا; MIMIC®; Modular IMmune In vitro Construct; TIV; trivalent influenza vaccine; PBMC; peripheral blood mononuclear cells; APC; antigen presenting cell; SA-HAI; surface assisted-hemagglutination inhibition assay; ICCS; intracellular cytokine staining; CDDC;
Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects
Keywords: واکسن سه واکنش آنفلوانزا; Influenza vaccine; MF59; Adjuvant; Non-inferiority; Superiority; Elderly; AE; adverse event; aTIV; adjuvanted trivalent influenza vaccine; CBER; Center for Biologics Evaluation and Research; CHMP; European Committee for Medicinal Products for Human Use; F
Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59®-adjuvanted influenza vaccine in infants and young children
Keywords: واکسن سه واکنش آنفلوانزا; Influenza vaccine; MF59; Adjuvant; Children; Fluad®; (www.clinicaltrials.gov): NCT01346592; AE; adverse event; aTIV; adjuvanted trivalent influenza vaccine; CI; confidence interval; FAS; full analysis set; GMT; geometric mean titer; HI; hemagglutination
Immunogenicity and safety of Fluzone® intradermal and high-dose influenza vaccines in older adults â¥65 years of age: A randomized, controlled, phase II trial
Keywords: واکسن سه واکنش آنفلوانزا; AE; adverse event; CI; confidence interval; GMT; geometric mean titer; HA; hemagglutinin; HI; hemagglutination inhibition; HD; high-dose inactivated trivalent influenza vaccine (60 μg HA/strain) for the intramuscular route; ID; intradermal; IM; intramus
Vaccines as a tool to estimate the burden of severe influenza in children of low-resourced areas (November 30-December 1, 2012, Les Pensieres, Veyrier-du-Lac, France)
Keywords: واکسن سه واکنش آنفلوانزا; BMFG; Bill & Melinda Gates Foundation; GABRIEL; global approach to biological research on infectious epidemics in low-income countries network; Hib; Haemophilus influenzae type b; HIV; human immunodeficiency virus; LAIV; live attenuated influenza vaccine;
Influenza vaccination in the 2009-2010 pandemic season: The experience of primary care physicians
Keywords: واکسن سه واکنش آنفلوانزا; pH1N1 vaccine; 2009 Influenza A (H1N1) monovalent vaccine); CI; Confidence Interval; wks; weeks; mos; months; yrs; years; TIV; trivalent influenza vaccine; Peds; Pediatricians; FM; Family Medicine physicians; GIM; General Internal Medicine physicians; AAP
Febrile seizures after 2010–2011 influenza vaccine in young children, United States: A vaccine safety signal from the vaccine adverse event reporting system
Keywords: واکسن سه واکنش آنفلوانزا; Febrile seizure; Trivalent influenza vaccine; Vaccine safety; Post-marketing surveillance
Adverse reactions to vaccines practice parameter 2012 update
Keywords: واکسن سه واکنش آنفلوانزا; Vaccine; immunization; adverse reaction; allergy; influenza vaccine; egg allergy; AAAAI; American Academy of Allergy, Asthma & Immunology; AAP; American Academy of Pediatrics; ACAAI; American College of Allergy, Asthma & Immunology; CDC; US Centers for Di
Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: A database study
Keywords: واکسن سه واکنش آنفلوانزا; GPRD; General Practice Research Database; TIV; trivalent influenza vaccine; Convulsions; Influenza vaccine; Monovalent H1N1 vaccine; Vaccine associated adverse events; Self-controlled case-series method;
Trivalent influenza vaccine and febrile adverse events in Australia, 2010: Clinical features and potential mechanisms
Keywords: واکسن سه واکنش آنفلوانزا; TIV; trivalent influenza vaccine; WA; Western Australia; PBMCs; peripheral blood mononuclear cells; ACIR; Australian Childhood Immunisation Register; LPS; lipopolysaccharide; SEB; staphylococcal enterotoxin B; PMH; Princess Margaret Hospital; IQ; interqua
Frequencies of human influenza-specific antibody secreting cells or plasmablasts post vaccination from fresh and frozen peripheral blood mononuclear cells
Keywords: واکسن سه واکنش آنفلوانزا; ASC; antibody secreting cell; PBMC; peripheral blood mononuclear cells; TIV; trivalent influenza vaccine; Antibody secreting cells; Plasmablasts; Vaccine; Influenza;